FULC earnings: a positive outcome, +10.3%

On July 31, 2024, Fulcrum Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.3% in the window around the event. It had already run +40.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.